Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Pfizer Inc
Form 13F · Q2 2026

Pfizer Inc

CIK 78003Filed 2026-08-1313F-HR View the filing on EDGAR ↗
$170M
Reported book value
20
Positions
7
Quarters on record
Top 50
Positions

Pfizer Inc — holdings

Top 17 positions of 20, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1ALLO Allogene Therapeutics Inc22.0M+0.0%$47M27.5%
2CELC Celcuity Inc295,652+0.0%$30M17.3%
3ARVN Arvinas Inc3.5M+0.0%$28M16.2%
4PYXS Pyxis Oncology Inc7.0M+0.0%$19M11.4%
5WVE Wave Life Sciences Ltd1.9M+0.0%$11M6.4%
6BHVN Biohaven Ltd505,645+0.0%$8M4.7%
7CRBU Caribou Biosciences Inc4.7M+0.0%$8M4.6%
8SPRO Spero Therapeutics Inc2.4M+0.0%$5M3.1%
9ZNTL Zentalis Pharmaceuticals Inc953,834+0.0%$4M2.3%
10ORIC Oric Pharmaceuticals Inc372,904−92.2%$4M2.1%
11CRDF Cardiff Oncology Inc2.4M+0.0%$3M1.8%
12ZURA Zura Bio Ltd538,841−81.0%$3M1.7%
13AGMB Agomab Therapeutics Nv75,000+0.0%$1M0.6%
14BOLT Bolt Biotherapeutics Inc31,305+0.0%$133,8320.1%
15NXTC Nextcure Inc44,347−71.1%$72,9670.0%
16DNA Ginkgo Bioworks Holdings Inc2,928+0.0%$30,0120.0%
17SENS Senseonics Hldgs Inc2,171+0.0%$12,4180.0%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.